UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Le Plan Cancer et La Mission Cancer de la Commission Européenne : la leucémie à promyélocytes inspiratrice du traitement personnalisé des cancers

Bulletin de l'Académie nationale de médecine, 2023-04, Vol.207 (4), p.431-433

Chomienne, C.

2023

Volltextzugriff (PDF)

Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms

Leukemia, 2008-11, Vol.22 (11), p.1990-1998

2008

Volltextzugriff (PDF)

AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages

Cell death & disease, 2015-08, Vol.6 (8), p.e1856-e1856

2015

Volltextzugriff (PDF)

Preclinical modeling of myelodysplastic syndromes

Leukemia, 2017-12, Vol.31 (12), p.2702-2708

2017

Volltextzugriff (PDF)

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia

Journal of medical genetics, 2010-10, Vol.47 (10), p.686-691

2010

Volltextzugriff (PDF)

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

British journal of cancer, 2009-03, Vol.100 (6), p.918-922

2009

Volltextzugriff (PDF)

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia

Leukemia, 2016-11, Vol.30 (11), p.2169-2178

2016

Volltextzugriff (PDF)

From Noonan syndrome to juvenile myelomonocytic leukemia

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2008-06, Vol.15 (5), p.812-813

2008

Volltextzugriff (PDF)

Pathologies d'activation de la voie RAS : du syndrome de Noonan aux leucémies myélomonocytaires juvéniles

Archives de pédiatrie (Paris), 2008-06, Vol.15 (5), p.812-813

2008

Volltextzugriff (PDF)

Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent

Leukemia, 2015-12, Vol.29 (12), p.2277-2284

2015

Volltextzugriff (PDF)

Correction for Cassinat et al., "New Role for Granulocyte Colony-Stimulating Factor-Induced Extracellular Signal-Regulated Kinase 1/2 in Histone Modification and Retinoic Acid Receptor α Recruitment to Gene Promoters: Relevance to Acute Promyelocytic Leukemia Cell Differentiation"

Molecular and cellular biology, 2017-07, Vol.37 (14)

2017

Volltextzugriff (PDF)

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia

Leukemia, 2013-12, Vol.27 (12), p.2404-2407

2013

Volltextzugriff (PDF)

Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma

Leukemia, 2007-01, Vol.21 (1), p.158-163

2007

Volltextzugriff (PDF)

New Role for Granulocyte Colony-Stimulating Factor-Induced Extracellular Signal-Regulated Kinase 1/2 in Histone Modification and Retinoic Acid Receptor α Recruitment to Gene Promoters: Relevance to Acute Promyelocytic Leukemia Cell Differentiation

Molecular and Cellular Biology, 2011-04, Vol.31 (7), p.1409-1418

2011

Volltextzugriff (PDF)

Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia Group

Journal of clinical oncology, 2005-01, Vol.23 (1), p.120-126

2005

Volltextzugriff (PDF)

Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1404-1412

2004

Volltextzugriff (PDF)

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Leukemia, 2006-01, Vol.20 (1), p.35-41

2006

Volltextzugriff (PDF)

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential

Oncogene, 2012-05, Vol.31 (19), p.2438-2449

2012

Volltextzugriff (PDF)

Use of the 46/1 haplotype to model JAK2(V617F) clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Leukemia, 2014-02, Vol.28 (2), p.460-463

2014

Volltextzugriff (PDF)

Développement d’un nouvel agent théranostique liposomal anti-CD44 pour le traitement de cancers

Médecine nucléaire : imagerie fonctionelle et métabolique, 2018-05, Vol.42 (3), p.154-154

2018

Volltextzugriff (PDF)

Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ―/― mice

Leukemia, 2012-11, Vol.26 (11), p.2432-2435

2012

Volltextzugriff (PDF)

Prognostic implication of FLT3 and ras gene mutations in patients with acute promyelocytic leukemia (APL) : a retrospective study from the european APL group

Leukemia, 2005-07, Vol.19 (7), p.1153-1160

2005

Volltextzugriff (PDF)

Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells

Oncogene, 2007-06, Vol.26 (27), p.4018-4024

2007

Volltextzugriff (PDF)

Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex

Molecular and Cellular Biology, 1999-10, Vol.19 (10), p.7158-7167

1999

Volltextzugriff (PDF)

1 – 25 von 399

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(351)
Mit Volltextzugriff
(307)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(198)
Science & Technology
(178)
Life Sciences & Biomedicine
(170)
Hematology
(102)
Biological And Medical Sciences
(101)
Medical Sciences
(94)
Oncology
(81)
Leukemia, Promyelocytic, Acute - Drug Therapy
(60)
Female
(55)
Male
(51)
Tretinoin - Therapeutic Use
(48)
Hematologic And Hematopoietic Diseases
(47)
Tretinoin - Pharmacology
(47)
Cell Differentiation - Drug Effects
(46)
Pharmacology. Drug Treatments
(45)
Middle Aged
(44)
Leukemia
(43)
Animals
(42)
Adult
(40)
Aged
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Le Plan Cancer et La Mission Cancer de la Commission Européenne : la leucémie à promyélocytes inspiratrice du traitement personnalisé des cancers

Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages

Preclinical modeling of myelodysplastic syndromes

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia

From Noonan syndrome to juvenile myelomonocytic leukemia

Pathologies d'activation de la voie RAS : du syndrome de Noonan aux leucémies myélomonocytaires juvéniles

Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent

Correction for Cassinat et al., "New Role for Granulocyte Colony-Stimulating Factor-Induced Extracellular Signal-Regulated Kinase 1/2 in Histone Modification and Retinoic Acid Receptor α Recruitment to Gene Promoters: Relevance to Acute Promyelocytic Leukemia Cell Differentiation"

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia

Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma

New Role for Granulocyte Colony-Stimulating Factor-Induced Extracellular Signal-Regulated Kinase 1/2 in Histone Modification and Retinoic Acid Receptor α Recruitment to Gene Promoters: Relevance to Acute Promyelocytic Leukemia Cell Differentiation

Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia Group

Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential

Use of the 46/1 haplotype to model JAK2(V617F) clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Développement d’un nouvel agent théranostique liposomal anti-CD44 pour le traitement de cancers

Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ―/― mice

Prognostic implication of FLT3 and ras gene mutations in patients with acute promyelocytic leukemia (APL) : a retrospective study from the european APL group

Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells

Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex

Suchergebnisse filtern